National Cancer Institute–Supported Obesity and Cancer Research, 2015-2022

In this descriptive study of the FYs 2015 to 2022 obesity and cancer grants portfolio, results showed that the NCI has consistently supported study of this critical research area, establishing a strong evidence base. Understanding the complex intersection of obesity and cancer requires sustained, multidisciplinary research. Multiple opportunities exist for advancing the science, including less studied areas, such as obesity’s impact on cancer treatment and survivorship, obesity and cancer throughout the lifespan, obesity and cancer disparities, and the study of obesity as it relates to multiple cancer sites; additionally, as use of GLP-1 medications continues to expand, new opportunities may emerge to examine how intentional, pharmacologically induced weight loss may influence cancer risk, treatment response, and survivorship.

Corresponding Author: Tanya Agurs-Collins, PhD, RD, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD (collinsta@mail.nih.gov).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.